How much does one month of treatment with dabrafenib and trametinib cost? Drug cost comparison

Dabrafenib and Trametinib (Trametinib) are important targeted drugs for the treatment of BRAF mutation-related tumors and are widely used in the treatment of diseases such as melanoma and non-small cell lung cancer. In terms of treatment costs, there are large differences between the two due to different dosage specifications and market channels. Trametinib has been launched in China and is included in medical insurance. It is available in two specifications: 0.5mg and 2mg. The price range is relatively flexible to meet the medication needs of different patients.

Specifically, the latest selling price of trametinib0.5mg30 tablets is about three to four thousand yuan, while the selling price of 2mg30 tablets is between more than nine thousand to more than ten thousand yuan. The specific price varies depending on regional medical insurance policies. In foreign markets, the Turkish original version of 2mg*30trametinib tablets is priced at around 7,000 to 8,000 yuan. It is worth mentioning that the Ministry of Health of Laos has approved the launch of a generic version of Trametinib. The price of this generic version has been significantly reduced, to only more than one thousand yuan, and its ingredients are basically the same as the original drug, providing patients with more affordable options.

Dabrafenib has also been launched in China and is included in medical insurance. The common specification is 75mg*120 tablets, and the price ranges from more than 9,000 to more than 10,000 yuan. The price of the original Turkish version of dabrafenib abroad is slightly higher, about 11,000 yuan. The price of the Lao version of dabrafenib generic drug is lower, with the latest price being about 2,000 yuan. It also ensures the same ingredients and efficacy as the original drug, greatly reducing the financial burden on patients.

Taken together, the domestic drug prices of dabrafenib and trametinib are relatively high, but medical insurance coverage has effectively alleviated patients’ medication pressure. The emergence of generic drugs in Laos provides patients with more economical options, especially for price-sensitive patient groups. When choosing medications, patients should reasonably choose appropriate drugs and purchase channels based on their own financial situation and doctor's recommendations to ensure treatment effects and medication safety.

Reference materials:https://go.drugbank.com/drugs/DB08912